1. Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials. Issue 7 (15th May 2018) Authors: Bussel, James; Arnold, Donald M.; Grossbard, Elliot; Mayer, Jiří; Treliński, Jacek; Homenda, Wojciech; Hellmann, Andrzej; Windyga, Jerzy; Sivcheva, Liliya; Khalafallah, Alhossain A.; Zaja, Francesco; Cooper, Nichola; Markovtsov, Vadim; Zayed, Hany; Duliege, Anne‐Marie Journal: American journal of hematology Issue: Volume 93:Issue 7(2018:Jul.) Page Start: 921 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program. Issue 5 (13th March 2019) Authors: Bussel, James B.; Arnold, Donald M.; Boxer, Michael A.; Cooper, Nichola; Mayer, Jiri; Zayed, Hany; Tong, Sandra; Duliege, Anne‐Marie Journal: American journal of hematology Issue: Volume 94:Issue 5(2019:May) Page Start: 546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗